All IMO - So lets be clear - which of your statements are actually factually correct?? Such a fluid opinion but so definite in your statements and claiming to be so informed and educated or just trying to muddy waters?.
Hey but perhaps pulling a shareholder name and their investment decision "Mark Gregory Kerr LLB you silly billy." out of the blue because you obviously know his full investment circumstances and his links to..........oh well- that would means facts and research.
Yeah that supports whatever you are saying and is somehow relevant ?.
"Just a final word for the week. The time waiting is frustrating BUT contrary to what a couple of naysayers have been posting
1. The arbitration seat is Singapore which is considered safe and that means the law is Singaporean not Indian.
2. Arbitration awards are far safer than International Court awards when it comes to enforcement. .. NY Convention provides strict regime for compliance.
3. Very limited grounds for appeal. ...
not even an error or fact of law! Most common attempt is arbitrators lack of reasons for his/ her decision. Given the time taken, I think these bases will be covered."
"T.W ...Stop the scaremongering. The gist of the conversation is all yours and you admit yourself you don't know.
The defendant is Mylan and their subsidiary in Singapore is holding a 200 m corporate guarantee plus 62 m in escrow. This has nothing to do with India. ( Incidentally, India are a signatory to the New York Convention and do respect their inclusion )
"
"Law School 101- you don't sue a company or individual who doesn't have assets. Corporate guarantee and escow money 262 m, Mylan Laboratories 1.5 b? Look, enforcement will happen if necessary but unlikely as already extensively detailed. "
"Lawyers even experienced ones miss things'
SOp we have paid Corrs 8 million because they are experts in international disputes. Corrs ..' mitigation of risk in cross border disputes starts with an effective and enforceable Dispute Resolution Clause'
It is their job to ensure ' great care is taken to ensure the arbitration clause is drafted in such a way to maximize the prospect of the award being enforced'.
For what it's worth the reason I believe there has been no settlement to date is
because of a possible conflict of interest on Mylan Laboratories board. This director was an the Matrix board pre Mylan Laboratories and he also sits on the board of Shasun Pharma and Shasun Solutions. He is also an Associate of the Insurance Institute of India. He would have been strategically involved in the sale of Agila. That's my conspiracy theory. All IMO "
(20min delay)